Asep Medical Holdings Inc. SEC filings SEPSF
Asep Medical Holdings Inc. has 8 filings in SEC EDGAR's recent list, going back to Jul 3, 2023. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SEC STAFF ACTION | Filing | Sep 10, 2025 | — |
| DRS/A | Filing | Jan 19, 2024 | — |
| DRS/A | Filing | Dec 12, 2023 | — |
| DRS/A | Filing | Oct 20, 2023 | — |
| DRS | Filing | Jul 3, 2023 | — |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- SEPSF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Victoria, British Columbia, Canada
- SEC CIK
- 1969766
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Achieve Life Sciences, Inc. ACHV
- Myriad Genetics Inc MYGN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.